Skip to main content
. 2023 Jan 26;14:1069974. doi: 10.3389/fimmu.2023.1069974

Table 4.

The frequency of carrying at least one of the HLA-DRB1*03/X genotypes in patients grouped according to presence or absence of at least one of the investigated autoantibody classes and low or normal plasma MBL levels.

HLA-DRB1 genotype 0 AB ≥1 AB
MBL ≤500 µg/l
Ntotal = 35
N (%)
MBL >500 µg/l
Ntotal = 60
N (%)
Pa MBL ≤500 µg/l
Ntotal = 22
N (%)
MBL >500 µg/l
Ntotal = 17
N (%)
Pb
01/03 5 (14.3) 8 (13.3) 1.0 4 (18.2) 1 (5.9) 0.36
03/03 3 (8.6) 4 (6.7) 1.0 1 (4.5) 1 (5.9) 1.0
03/04 7 (20.0) 12 (20.0) 1.0 1 (4.5) 4 (23.5) 0.15
03/07 5 (14.3) 8 (13.3) 1.0 3 (13.6) 0 (0.0) 0.24
03/08 1 (2.9) 0 (0.0) 0.37 2 (9.1) 3 (17.6) 0.64
03/09 1 (2.9) 3 (5.0) 1.0 0 (0.0) 0 (0.0)
03/10 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
03/11 or 03/12 3 (8.6) 5 (8.3) 1.0 2 (9.1) 2 (11.8) 1.0
03/13 5 (14.3) 9 (15.0) 1.0 2 (9.1) 1 (5.9) 1.0
03/14 0 (0.0) 2 (3.3) 0.53 2 (9.1) 1 (5.9) 1.0
03/15 4 (11.4)* 8 (13.3)* 1.0 5 (22.7)* 4 (23.5)* 1.0
03/16 1 (2.9) 1 (1.7) 1.0 0 (0.0) 0 (0.0)

AB, antibody; MBL, mannose-binding lectin a,b Comparing patients with low or normal p-MBL; *, comparing patients without autoantibodies with genotype HLA-DRB1*03/15 versus patients with autoantibodies without the genotype, p = 0.13.